April 10, 2026 17:02 ET | Source: Replimune, Inc. WOBURN, Mass., April 10, 2026 (GLOBE NEWSWIRE) -- Replimune Group, Inc.…
Rapid expansion of agentic AI across major markets enabled by a new unlimited Agentic Enterprise license agreement with SalesforceAgreement underpins…
PHILADELPHIA and VANCOUVER, British Columbia, Feb. 18, 2026 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ, BCTXL) (TSX:…
HAMILTON, Bermuda, Feb. 17, 2026 /PRNewswire/ -- DerivaDEX today announced the launch of its platform and the start of derivatives trading…
If approved, LEQEMBI IQLIK would be the first and only anti-amyloid treatment to offer at-home injection options for initiation and…
LEAWOOD, Kan., Jan. 09, 2026 (GLOBE NEWSWIRE) -- Etienna Bio, Inc., a biotechnology company focused on next-generation autologous and cell-enabled…
Saint-Herblain (France), Pune, (India), December 31, 2025 – Valneva SE (“Valneva” or “the Company”), a specialty vaccine company, and Serum…
HOD HASHARON, Israel, Dec. 28, 2025 (GLOBE NEWSWIRE) -- Weebit Nano Limited (ASX:WBT) (Weebit or Company), a leading developer and…
VIENNA, Austria, Nov. 28, 2025 /PRNewswire/ -- KuCoin, a leading global crypto platform built on trust, today announced that its European…
Atacicept received FDA Breakthrough Therapy Designation for the treatment of IgANORIGIN Phase 3 trial met its primary endpoint at the…